GSK

Showing 15 posts of 760 posts found.

filippo_6_for_internal_use_online

GSK Consumer Healthcare announces new Asia Pacific Regional Head

January 16, 2018
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing GSK, GlaxoSmithKline

GlaxoSmithKline’s Consumer Healthcare business has revealed that Filippo Lanzi is to take over as Regional Head of Asia Pacific, overseeing …

nice_new_london_office_internal_3_web

NICE recommends first overseas treatment for use on NHS with GSK ‘bubble baby’ gene therapy

January 4, 2018
Sales and Marketing ADA-SCID, GSK, GlaxoSmithKline, NHS, NICE, Strimvelis, bubble baby, pharma

NICE has chalked up a new first in its assessment of treatments for use on the NHS, ruling that the …

gsk_boronia_australia

GSK forced to pay back £1.5m to Scottish Government after recent job cuts

December 20, 2017
Manufacturing and Production, Research and Development GSK, GlaxoSmithKline, pharma

British pharmaceutical giant GlaxoSmithKline has been ordered to pay back £1.5 million to the Scottish Government because of its failure …

news_accc

Two big pharma companies accused of false marketing

December 6, 2017
Research and Development, Sales and Marketing GSK, Novartis, biotech, drugs, pharma, pharmaceutical

Novartis and GSK have been taken to court by the Australian Competition and Consumer Commission (ACCC) over allegations of falsely …

gsk_wall

GSK commits to multi-million investment in UK life sciences sector deal

December 6, 2017
Research and Development, Sales and Marketing GSK, biotech, drugs, pharma, pharmaceutical

In the latest boost to the UK’s life sciences strategy, GSK has committed £40 million to its work identifying new …

gsk_boronia_australia

FDA approves first-ever two-drug HIV regimen, GSK’s Juluca

November 22, 2017
Research and Development, Sales and Marketing AIDS, FDA, GSK, Gilead, GlaxoSmithKilne, HIV, Juluca, ViiV Healthcare, pharma

GlaxoSmithKline has announced that the FDA has awarded US marketing authorisation to the first two-drug regimen in the treatment of …

GSK gets EU go-ahead for triple therapy inhaler in COPD

November 16, 2017
Sales and Marketing COPD, FDA, GSK, Trelegy Ellipta, pharma

The EMA has awarded EU marketing authorisation to GlaxoSmithKline and Innovia’s single inhaler triple therapy Trelegy Ellipta (fluticasone furoate/umeclidinium/vilanterol) for …

gsk_wall

GSK indicates a return to oncology by appointing Roche veteran

November 9, 2017
Medical Communications GSK, Hal Barron, biotech, drugs, pharma, pharmaceutical

GSK, under its new CEO, has made most of its waves recently not with approvals but with high-profile appointments, and …

dr-patrick-vallance-gsk

GSK’s R&D head to move on after shift in focus

November 3, 2017
Medical Communications GSK, biotech, drugs, pharma, pharmaceutical

There has been a raft of changes at senior levels of GSK since Emma Walmsley took over the role from …

andrew_witty_gsk_new

Witty to lead way in fast-tracking medicine through UK system

November 3, 2017
Medical Communications AAR, Andrew Witty, GSK, biotech, drugs, pharma, pharmaceutical

The UK government has announced its response to the Accelerated Access Review that was published last year, with former GSK …

gsk_boronia_australia

GSK’s experimental multiple myeloma scores Breakthrough designation with FDA

November 3, 2017
Medical Communications, Research and Development, Sales and Marketing Cancer, FDA, GSK, GlaxoSmithKline, multiple myeloma, pharma

GlaxoSmithKline is celebrating the FDA’s decision to award its experimental therapy GSK2857916 with Breakthrough Therapy Designation as a monotherapy in …

gsk_wall

GSK eyes healthcare expansion, hits targets due to new drugs

October 26, 2017
Sales and Marketing GSK, Merck KGaA, Pfizer, biotech, drugs, healthcare, pharma, pharmaceutical

During the release of Q3 figures, GlaxoSmithKline’s CEO, Emma Walmsley, revealed that the company would consider making moves to bolster …

Pfizer to begin auction of consumer health division next month

October 26, 2017
Sales and Marketing GSK, Pfizer, Proctor & Gamble, Sanofi, nestle

Following the recent revelation that Pfizer was considering the spin-out of its consumer health division, it has now emerged that …

GSK’s ‘bubble boy’ gene therapy secures NICE recommendation despite high cost

October 25, 2017
Research and Development, Sales and Marketing GSK, GlaxoSmithKline, Strimvelis, pharma

GSK has received good news from NICE as it is revealed that Strimvelis, its gene therapy treatment for adenosine deaminase …

shutterstock_138095450

AZ tops annual R&D spend in UK, Roche is greatest pharma spender worldwide

October 24, 2017
Manufacturing and Production, Research and Development, Sales and Marketing AstraZeneca, GSK, GlaxoSmithKline, R&D, Roche, pwC

New findings of a report by PwC have revealed the biggest spenders in R&D worldwide as global spending hits $700 …

The Gateway to Local Adoption Series

Latest content